Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Mitochondria-Targeted Drug Development"

From Bioblast
Β 
(One intermediate revision by the same user not shown)
Line 2: Line 2:
|abbr=hansonwade
|abbr=hansonwade
|description=[[File:21640 - Mitochondria Targeted Therapeutics logo NEW.jpg|200px|left|Mitochondria-Targeted Drug Development]]
|description=[[File:21640 - Mitochondria Targeted Therapeutics logo NEW.jpg|200px|left|Mitochondria-Targeted Drug Development]]
The '''Mitochondria-Targeted Drug Development''' was established in ## and their research focuses on ##
The '''Mitochondria-Targeted Drug Development Summit''' was first established in 2021, as an online conference. Due to its success and unmatched focus, the 2<sup>nd</sup> edition returns to Boston this March 2022.
Since ## this research group organizes the annual conference [https://mitochondria-targets.com/ "Mitochondria-Targeted Drug Development"].
This is the only industry-led meeting that unites key stakeholders under a mutual and ambitious objective of '''accelerating the discovery and development of novel drugs that target mitochondrial functions''' for chronic, primary mitochondrial diseases, muscular dystrophy, metabolic disorders, and neurodegenerative diseases.
Join our speakers from '''GenSight Biologics, Abliva, Reneo Pharma, Mito BioPharma, Mitokinin''' and more with exciting networking opportunities, panel discussions and dedicated roundtables.
|info=[https://mitochondria-targets.com/program/full-event-guide/?utm_source=external&utm_medium=event-listing&utm_campaign=event-listing&utm_content=media-partner/other-mitoglobal-/unpaid/ev-26959 hansonwade]
|info=[https://mitochondria-targets.com/program/full-event-guide/?utm_source=external&utm_medium=event-listing&utm_campaign=event-listing&utm_content=media-partner/other-mitoglobal-/unpaid/ev-26959 hansonwade]
}}
}}
Line 16: Line 17:
:::: E-mail: [email protected]
:::: E-mail: [email protected]


===Chairman===
=== Conference address===
Β 
Β 
===Business address===
:::: Hyatt Regency Boston / Cambridge
:::: Hyatt Regency Boston / Cambridge
:::: 575 Memorial Dr
:::: 575 Memorial Dr
Line 29: Line 27:


::::* [[Mitochondria-Targeted Drug Development 2022 Boston US]]<br>
::::* [[Mitochondria-Targeted Drug Development 2022 Boston US]]<br>
::::* [[Mitochondria-Targeted Drug Development 2021 Virtual]]


{{MitoGlobal_Societies}}
{{MitoGlobal_Societies}}

Latest revision as of 09:13, 29 November 2021


high-resolution terminology - matching measurements at high-resolution


Mitochondria-Targeted Drug Development

Description

Mitochondria-Targeted Drug Development

The Mitochondria-Targeted Drug Development Summit was first established in 2021, as an online conference. Due to its success and unmatched focus, the 2nd edition returns to Boston this March 2022. This is the only industry-led meeting that unites key stakeholders under a mutual and ambitious objective of accelerating the discovery and development of novel drugs that target mitochondrial functions for chronic, primary mitochondrial diseases, muscular dystrophy, metabolic disorders, and neurodegenerative diseases. Join our speakers from GenSight Biologics, Abliva, Reneo Pharma, Mito BioPharma, Mitokinin and more with exciting networking opportunities, panel discussions and dedicated roundtables.

Abbreviation: hansonwade

Reference: hansonwade



MitoPedia topics: MitoGlobal Organizations 

MitoGlobal

Contact details

T: (+1) 617 455 4188
E-mail: [email protected]

Conference address

Hyatt Regency Boston / Cambridge
575 Memorial Dr
Cambridge
MA 02139
United States

Links:


Listed as a MitoGlobal Society.

MitoGlobal         MitoEAGLE         MitoGlobal Societies         MiPsociety         ASMRM         MitoGlobal Events         MitoGlobal first